22
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Submit your digital health research with an established publisher
      - celebrating 25 years of open access

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Exploring Digital Biomarkers of Illness Activity in Mood Episodes: Hypotheses Generating and Model Development Study

      research-article
      , MD 1 , 2 , 3 , 4 , 5 , , MD 6 , , MSc 6 , , PsyD 1 , 2 , 3 , 4 , 5 , , PsyD, PhD 1 , 2 , 3 , 4 , 5 , , MD, PhD 1 , 2 , 3 , 4 , 5 , , MD, PhD 1 , 2 , 3 , 4 , 5 , , MD, PhD 1 , 2 , 3 , 4 , 5 , , MD, PhD 1 , 2 , 3 , 4 , 5 , , MD 1 , 2 , 3 , 4 , 5 , , MD, PhD 1 , 2 , 3 , 4 , 5 , , RNC 1 , , RNC 1 , 4 , 5 , , MD, PhD 1 , 2 , 3 , 4 , 5 , , MD 1 , , MD 1 , 3 , 4 , 5 , 7 , , MD, PhD 1 , 3 , 4 , 5 , 7 , , MD, PhD 1 , 3 , 4 , 5 , 7 , , MD, PhD 1 , 2 , 3 , 4 , 5 , , MD 1 , 3 , 4 , 5 , 7 , , MD, PhD 1 , 2 , 3 , 4 , 5 , , PsyD, PhD 1 , 2 , 3 , 4 , 5 , , PsyD, PhD 1 , 2 , 3 , 4 , 5 , , RNC 1 , , MD 1 , 2 , 3 , 4 , 5 , , MD 1 , 2 , 3 , 4 , 5 , , MD 1 , 2 , 3 , 4 , 5 , , MSc, PhD 2 , 4 , 5 , 8 , , MD, PhD 2 , 4 , 5 , 8 , 9 , 10 , , MD, PhD 11 , 12 , , MD, PhD 13 , , MD, PhD 1 , 2 , 3 , 4 , 5 , , MSc, PhD 6 , , MD, PhD 1 , 2 , 3 , 4 , 5 ,
      (Reviewer), (Reviewer), (Reviewer), (Reviewer)
      JMIR mHealth and uHealth
      JMIR Publications
      depression, mania, bipolar disorder, major depressive disorder, machine learning, deep learning, physiological data, digital biomarker, wearable, Empatica E4

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Depressive and manic episodes within bipolar disorder (BD) and major depressive disorder (MDD) involve altered mood, sleep, and activity, alongside physiological alterations wearables can capture.

          Objective

          Firstly, we explored whether physiological wearable data could predict (aim 1) the severity of an acute affective episode at the intra-individual level and (aim 2) the polarity of an acute affective episode and euthymia among different individuals. Secondarily, we explored which physiological data were related to prior predictions, generalization across patients, and associations between affective symptoms and physiological data.

          Methods

          We conducted a prospective exploratory observational study including patients with BD and MDD on acute affective episodes (manic, depressed, and mixed) whose physiological data were recorded using a research-grade wearable (Empatica E4) across 3 consecutive time points (acute, response, and remission of episode). Euthymic patients and healthy controls were recorded during a single session (approximately 48 h). Manic and depressive symptoms were assessed using standardized psychometric scales. Physiological wearable data included the following channels: acceleration (ACC), skin temperature, blood volume pulse, heart rate (HR), and electrodermal activity (EDA). Invalid physiological data were removed using a rule-based filter, and channels were time aligned at 1-second time units and segmented at window lengths of 32 seconds, as best-performing parameters. We developed deep learning predictive models, assessed the channels’ individual contribution using permutation feature importance analysis, and computed physiological data to psychometric scales’ items normalized mutual information (NMI). We present a novel, fully automated method for the preprocessing and analysis of physiological data from a research-grade wearable device, including a viable supervised learning pipeline for time-series analyses.

          Results

          Overall, 35 sessions (1512 hours) from 12 patients (manic, depressed, mixed, and euthymic) and 7 healthy controls (mean age 39.7, SD 12.6 years; 6/19, 32% female) were analyzed. The severity of mood episodes was predicted with moderate (62%-85%) accuracies (aim 1), and their polarity with moderate (70%) accuracy (aim 2). The most relevant features for the former tasks were ACC, EDA, and HR. There was a fair agreement in feature importance across classification tasks (Kendall W=0.383). Generalization of the former models on unseen patients was of overall low accuracy, except for the intra-individual models. ACC was associated with “increased motor activity” (NMI>0.55), “insomnia” (NMI=0.6), and “motor inhibition” (NMI=0.75). EDA was associated with “aggressive behavior” (NMI=1.0) and “psychic anxiety” (NMI=0.52).

          Conclusions

          Physiological data from wearables show potential to identify mood episodes and specific symptoms of mania and depression quantitatively, both in BD and MDD. Motor activity and stress-related physiological data (EDA and HR) stand out as potential digital biomarkers for predicting mania and depression, respectively. These findings represent a promising pathway toward personalized psychiatry, in which physiological wearable data could allow the early identification and intervention of mood episodes.

          Related collections

          Most cited references118

          • Record: found
          • Abstract: found
          • Article: not found

          Attention Is All You Need

          The dominant sequence transduction models are based on complex recurrent or convolutional neural networks in an encoder-decoder configuration. The best performing models also connect the encoder and decoder through an attention mechanism. We propose a new simple network architecture, the Transformer, based solely on attention mechanisms, dispensing with recurrence and convolutions entirely. Experiments on two machine translation tasks show these models to be superior in quality while being more parallelizable and requiring significantly less time to train. Our model achieves 28.4 BLEU on the WMT 2014 English-to-German translation task, improving over the existing best results, including ensembles by over 2 BLEU. On the WMT 2014 English-to-French translation task, our model establishes a new single-model state-of-the-art BLEU score of 41.8 after training for 3.5 days on eight GPUs, a small fraction of the training costs of the best models from the literature. We show that the Transformer generalizes well to other tasks by applying it successfully to English constituency parsing both with large and limited training data. 15 pages, 5 figures
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            A RATING SCALE FOR DEPRESSION

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic

              (2021)
              Background Before 2020, mental disorders were leading causes of the global health-related burden, with depressive and anxiety disorders being leading contributors to this burden. The emergence of the COVID-19 pandemic has created an environment where many determinants of poor mental health are exacerbated. The need for up-to-date information on the mental health impacts of COVID-19 in a way that informs health system responses is imperative. In this study, we aimed to quantify the impact of the COVID-19 pandemic on the prevalence and burden of major depressive disorder and anxiety disorders globally in 2020. Methods We conducted a systematic review of data reporting the prevalence of major depressive disorder and anxiety disorders during the COVID-19 pandemic and published between Jan 1, 2020, and Jan 29, 2021. We searched PubMed, Google Scholar, preprint servers, grey literature sources, and consulted experts. Eligible studies reported prevalence of depressive or anxiety disorders that were representative of the general population during the COVID-19 pandemic and had a pre-pandemic baseline. We used the assembled data in a meta-regression to estimate change in the prevalence of major depressive disorder and anxiety disorders between pre-pandemic and mid-pandemic (using periods as defined by each study) via COVID-19 impact indicators (human mobility, daily SARS-CoV-2 infection rate, and daily excess mortality rate). We then used this model to estimate the change from pre-pandemic prevalence (estimated using Disease Modelling Meta-Regression version 2.1 [known as DisMod-MR 2.1]) by age, sex, and location. We used final prevalence estimates and disability weights to estimate years lived with disability and disability-adjusted life-years (DALYs) for major depressive disorder and anxiety disorders. Findings We identified 5683 unique data sources, of which 48 met inclusion criteria (46 studies met criteria for major depressive disorder and 27 for anxiety disorders). Two COVID-19 impact indicators, specifically daily SARS-CoV-2 infection rates and reductions in human mobility, were associated with increased prevalence of major depressive disorder (regression coefficient [ B ] 0·9 [95% uncertainty interval 0·1 to 1·8; p=0·029] for human mobility, 18·1 [7·9 to 28·3; p=0·0005] for daily SARS-CoV-2 infection) and anxiety disorders (0·9 [0·1 to 1·7; p=0·022] and 13·8 [10·7 to 17·0; p<0·0001]. Females were affected more by the pandemic than males ( B 0·1 [0·1 to 0·2; p=0·0001] for major depressive disorder, 0·1 [0·1 to 0·2; p=0·0001] for anxiety disorders) and younger age groups were more affected than older age groups (−0·007 [–0·009 to −0·006; p=0·0001] for major depressive disorder, −0·003 [–0·005 to −0·002; p=0·0001] for anxiety disorders). We estimated that the locations hit hardest by the pandemic in 2020, as measured with decreased human mobility and daily SARS-CoV-2 infection rate, had the greatest increases in prevalence of major depressive disorder and anxiety disorders. We estimated an additional 53·2 million (44·8 to 62·9) cases of major depressive disorder globally (an increase of 27·6% [25·1 to 30·3]) due to the COVID-19 pandemic, such that the total prevalence was 3152·9 cases (2722·5 to 3654·5) per 100 000 population. We also estimated an additional 76·2 million (64·3 to 90·6) cases of anxiety disorders globally (an increase of 25·6% [23·2 to 28·0]), such that the total prevalence was 4802·4 cases (4108·2 to 5588·6) per 100 000 population. Altogether, major depressive disorder caused 49·4 million (33·6 to 68·7) DALYs and anxiety disorders caused 44·5 million (30·2 to 62·5) DALYs globally in 2020. Interpretation This pandemic has created an increased urgency to strengthen mental health systems in most countries. Mitigation strategies could incorporate ways to promote mental wellbeing and target determinants of poor mental health and interventions to treat those with a mental disorder. Taking no action to address the burden of major depressive disorder and anxiety disorders should not be an option. Funding Queensland Health, National Health and Medical Research Council, and the Bill and Melinda Gates Foundation.
                Bookmark

                Author and article information

                Contributors
                Journal
                JMIR Mhealth Uhealth
                JMIR Mhealth Uhealth
                JMU
                JMIR mHealth and uHealth
                JMIR Publications (Toronto, Canada )
                2291-5222
                2023
                4 May 2023
                : 11
                : e45405
                Affiliations
                [1 ] Department of Psychiatry and Psychology Institute of Neuroscience Hospital Clínic de Barcelona Barcelona, Catalonia Spain
                [2 ] Bipolar and Depressive Disorders Unit Digital Innovation Group Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona, Catalonia Spain
                [3 ] Biomedical Research Networking Centre Consortium on Mental Health (CIBERSAM) Instituto de Salud Carlos III Madrid Spain
                [4 ] Department of Medicine School of Medicine and Health Sciences University of Barcelona (UB) Barcelona, Catalonia Spain
                [5 ] Institute of Neurosciences (UBNeuro) University of Barcelona Barcelona, Catalonia Spain
                [6 ] School of Informatics University of Edinburgh Edinburgh United Kingdom
                [7 ] Barcelona Clinic Schizophrenia Unit Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona, Catalonia Spain
                [8 ] Imaging of Mood- and Anxiety-Related Disorders (IMARD) Group Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona, Catalonia Spain
                [9 ] Early Psychosis: Interventions & Clinical-detection (EPIC) Lab, Department of Psychosis Studies Institute of Psychiatry Psychology and Neuroscience King's College London London United Kingdom
                [10 ] Center for Psychiatry Research Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden
                [11 ] Department of Psychiatry, Centre Hospitalier Universitaire (CHU) Clermont-Ferrand University of Clermont Auvergne, Centre National de la Recherche Scientifique (CNRS), Clermont Auvergne INP Institut Pascal (UMR 6602) Clermont-Ferrand France
                [12 ] Association Française de Psychiatrie Biologique et Neuropsychopharmacologie (AFPBN) Paris France
                [13 ] Centre for Affective Disorders Institute of Psychiatry, Psychology & Neuroscience King's College London London United Kingdom
                Author notes
                Corresponding Author: Diego Hidalgo-Mazzei dahidalg@ 123456clinic.cat
                Author information
                https://orcid.org/0000-0002-6798-4054
                https://orcid.org/0000-0002-6807-0617
                https://orcid.org/0000-0003-3144-4838
                https://orcid.org/0000-0002-8738-8655
                https://orcid.org/0000-0003-2206-2264
                https://orcid.org/0000-0002-7822-0367
                https://orcid.org/0000-0002-9783-6220
                https://orcid.org/0000-0002-0137-0666
                https://orcid.org/0000-0001-8814-2246
                https://orcid.org/0000-0002-9474-6473
                https://orcid.org/0000-0001-7312-4969
                https://orcid.org/0000-0002-0381-7951
                https://orcid.org/0000-0003-3749-4182
                https://orcid.org/0000-0002-5283-5523
                https://orcid.org/0000-0003-4572-8946
                https://orcid.org/0000-0002-2630-3259
                https://orcid.org/0000-0001-6887-7149
                https://orcid.org/0000-0002-4855-1608
                https://orcid.org/0000-0001-9488-2881
                https://orcid.org/0000-0002-1123-4211
                https://orcid.org/0000-0001-6320-4420
                https://orcid.org/0000-0001-6017-2734
                https://orcid.org/0000-0002-0623-6263
                https://orcid.org/0000-0001-9198-4663
                https://orcid.org/0000-0003-1785-7126
                https://orcid.org/0000-0002-2032-1181
                https://orcid.org/0000-0002-5961-6032
                https://orcid.org/0000-0002-2491-200X
                https://orcid.org/0000-0003-1240-5438
                https://orcid.org/0000-0003-0740-4019
                https://orcid.org/0000-0003-2291-6952
                https://orcid.org/0000-0002-0548-0053
                https://orcid.org/0000-0003-0036-5678
                https://orcid.org/0000-0002-2693-6849
                Article
                v11i1e45405
                10.2196/45405
                10196899
                36939345
                2e9f8a72-e59b-4ef2-80ac-2cb69c937025
                ©Gerard Anmella, Filippo Corponi, Bryan M Li, Ariadna Mas, Miriam Sanabra, Isabella Pacchiarotti, Marc Valentí, Iria Grande, Antoni Benabarre, Anna Giménez-Palomo, Marina Garriga, Isabel Agasi, Anna Bastidas, Myriam Cavero, Tabatha Fernández-Plaza, Néstor Arbelo, Miquel Bioque, Clemente García-Rizo, Norma Verdolini, Santiago Madero, Andrea Murru, Silvia Amoretti, Anabel Martínez-Aran, Victoria Ruiz, Giovanna Fico, Michele De Prisco, Vincenzo Oliva, Aleix Solanes, Joaquim Radua, Ludovic Samalin, Allan H Young, Eduard Vieta, Antonio Vergari, Diego Hidalgo-Mazzei. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 04.05.2023.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on https://mhealth.jmir.org/, as well as this copyright and license information must be included.

                History
                : 29 December 2022
                : 25 January 2023
                : 20 February 2023
                : 7 March 2023
                Categories
                Original Paper
                Original Paper

                depression,mania,bipolar disorder,major depressive disorder,machine learning,deep learning,physiological data,digital biomarker,wearable,empatica e4

                Comments

                Comment on this article